New approaches to the development of adenoviral dendritic cell vaccines in melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-408Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-7Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-97Dendritic cell-based immunotherapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-04 / Clin. Dev. Immunol. 2010;2010:517493RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-01 / Neoplasia 2010 Nov;12(11):906-14Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
/in Dendritic Cells, International Publications /von 2010-11-01 / Expert Opin Biol Ther 2010 Nov;10(11):1539-53[WT1 peptide pulsed dendritic cell therapy with activated T lymphocytes therapy for advanced cancers]
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2240-2Personalized cancer vaccines
/in Dendritic Cells, International Publications /von 2010-10-28 / Expert Opin Biol Ther 2010 Dec;10(12):1637-47
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de